Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • HIV Complications and Co-Morbidities
      • HIV Cure
      • HIV Treatment
      • Tuberculosis
      • Social Behavioral Scientific Core (SBSC)
    • Funding Acknowledgements
    • Network Sites
      • Site Map
    • Staff Spotlights
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • MiLab Resources
      • Specimen Repository
    • Manual of Procedures
    • Media Release Form
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.
Back to Directory

Tim Cressey

Email

tim.cressey@cmu.ac.th

Phone

66 53 819 125 9

Institution

Chiangrai Prachanukroh Hospital

Title

Address

Chiangrai Prachanukroh Hospital Clinical Research Site
1039 Sathanpayaban Road


Muang, Chiangrai
Thailand
Request an Update

Affiliated Studies

P1071: CCR5 Vicriviroc (SCH-417690)

DAIDS Number

10634

Research Area

N/A

Study Status

Concluded

P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY

DAIDS Number

10765

Research Area

Other

Study Status

Concluded

P1083: Kaletra/Aluvia PK study

DAIDS Number

10787

Research Area

Treatment

Study Status

Concluded

P1025: Perinatal Core Protocol

DAIDS Number

10039

Research Area

Prevention

Study Status

Concluded

P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations

DAIDS Number

10809

Research Area

Other

Study Status

Concluded
Show All
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

Sitemap

© 2020 IMPAACT Network